CN1476873A - Medicine composition for curing diarrhea - Google Patents
Medicine composition for curing diarrhea Download PDFInfo
- Publication number
- CN1476873A CN1476873A CNA021393869A CN02139386A CN1476873A CN 1476873 A CN1476873 A CN 1476873A CN A021393869 A CNA021393869 A CN A021393869A CN 02139386 A CN02139386 A CN 02139386A CN 1476873 A CN1476873 A CN 1476873A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- attapulgite
- ultra
- treatment diarrheal
- high pure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a medicine composition for curing diarrhea, and said composition is made up by using high purity and ultrafine attapulgite, broad-spectrum antimicrobial and sweetening agent through conventional preparation process. Said attapulgite is used as adsorbent, and can be used for adsorbing bacteria and toxin resulted in diarrhea in the body.
Description
Technical field
The present invention relates to a kind of treatment diarrheal pharmaceutical composition.
Background technology
Attapulgite is the fibrous magnesia silicate of water-bearing layer chain, and only a few countries or such mineral deposit of regional output in the world are rare in the world nonmetal mineral resources at present.Have good physical property and unique element, architectural feature, be characterized by good colloidal property, absorption property and catalytic performance.
Abroad, U.S. particularly, this such as has developed from the oil drilling slurry to the solar energy heat-storage at several thousand kinds of purposes of various fields, though China has this mineral products advantage, but less to this mineral composition, structure and physical and chemical performance research, only develop several prods such as mud, adsorbent.Thereby, on the basis that composition, the performance of this resource are further studied, are familiar with, further develop application widely, develop high-purity micron, submicron-grade superfine powder body material, application to the ecological agriculture and life and health field has crucial meaning.
Because ultra-fine attapulgite has that specific surface area is big, adsorptivity is strong, load is good, proportion is little, soda acid is moderate, pelletize uniformity, the characteristics such as depositing not classification of loosing.Therefore, the high pure and ultra-fine attapulgite can be used as the carrier of medicinal tool sustained release performance, improves the performance of medicine.
State such as the U.S., Britain once used Kaolin as medicine or carrier, but because of Al
3o
3Reasons such as content, give it up, only leave attapulgite at present as pharmacopeia listed medicinal materials or carrier material.
Summary of the invention
The objective of the invention is in order to provide a kind of treatment diarrhoea to be pharmaceutical composition.High pure and ultra-fine attapulgite in the said composition can be used for adsorbing generation diarrheal antibacterial and toxin in the human body as adsorbent, can significantly reduce the body fluid that causes because of diarrhoea simultaneously and run off.
Purpose of the present invention can realize by following measure:
A kind of treatment diarrheal pharmaceutical composition, make by known preparation process by following raw materials in percentage by weight:
High pure and ultra-fine attapulgite 20-100% broad spectrum activity antimicrobial drug 0-80%
Sweeting agent 0-80%.
Above-mentioned said composition is to be made by following raw materials in percentage by weight:
High pure and ultra-fine attapulgite 40-80% broad spectrum activity antimicrobial drug 10-60%
Sweeting agent 10-60%.
Above-mentioned broad spectrum activity antimicrobial drug is selected from least a in berberine hydrochloride, kanamycin sulfate and the high pure and ultra-fine attapulgite body.
Above-mentioned sweeting agent is selected from least a in sucrose, fructose, the propolis.
The dosage form of above-mentioned pharmaceutical composition is tablet, capsule, electuary.
The present invention has following advantage compared to existing technology:
To have specific surface area is big, adsorptivity is strong, load is good, proportion is little high pure and ultra-fine attapulgite in the medicine of the present invention both as treatment diarrheal medicine, again it be can be used as the carrier of the medicine of antibiotic, antiinflammatory; Thereby, high pure and ultra-fine attapulgite soil characteristics can control diarrhoea rapidly because can be used for adsorbing the toxin that produces generation in diarrheal antibacterial and the body; Simultaneously because its adsorptivity also can reduce the water loss that takes place because of diarrhoea, and avoid causing the dehydration that takes place because of water loss and the phenomenon of electrolyte disturbance.
The U.S., South Africa, countries such as method car use as essential drugs and carrier attapulgite in nonprescription drugs.
Concrete embodiment
The present invention also will be described in further detail in conjunction with the embodiments:
Embodiment one:
A kind of diarrheal pharmaceutical composition for the treatment of is made by the preparation process of known pharmaceutics by the high pure and ultra-fine attapulgite of weight percentage.
Embodiment two:
A kind of treatment diarrheal pharmaceutical composition is to be made by known electuary technology by following raw materials in percentage by weight: high pure and ultra-fine attapulgite 85%, sweeting agent 15%.
Embodiment three:
A kind of treatment diarrheal pharmaceutical composition is to be made by known capsule technology by following raw materials in percentage by weight: high pure and ultra-fine attapulgite 55%, kanamycin sulfate 30%, sweeting agent 15%.
Embodiment four:
A kind of treatment diarrheal pharmaceutical composition is to make medicament by following raw materials in percentage by weight by known preparation process: high pure and ultra-fine attapulgite 30%, berberine hydrochloride 60%, sweeting agent 10%.
Embodiment five:
A kind of treatment diarrheal pharmaceutical composition is to make medicament by following raw materials in percentage by weight by known preparation process: high pure and ultra-fine attapulgite 45%, berberine hydrochloride 55%.
Claims (5)
1, a kind of treatment diarrheal pharmaceutical composition, make by known preparation process by following raw materials in percentage by weight:
High pure and ultra-fine attapulgite 20-100% broad spectrum activity antimicrobial drug 0-80% sweeting agent 0-80%.
2, treatment diarrheal pharmaceutical composition as claimed in claim 1 is characterized in that said composition is to be made by following raw materials in percentage by weight:
High pure and ultra-fine attapulgite 40-80% broad spectrum activity antimicrobial drug 10-60% sweeting agent 10-60%.
3, treatment diarrheal pharmaceutical composition as claimed in claim 1, it is characterized in that described broad spectrum activity antimicrobial drug be selected from berberine hydrochloride, kanamycin sulfate, and attapulgite (high-purity) body at least a.
4, treatment diarrheal pharmaceutical composition as claimed in claim 1 is characterized in that described sweeting agent is selected from least a in sucrose, fructose, the propolis.
5, treatment diarrheal pharmaceutical composition as claimed in claim 1, the dosage form that it is characterized in that described pharmaceutical composition is tablet, capsule, electuary.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA021393869A CN1476873A (en) | 2002-08-20 | 2002-08-20 | Medicine composition for curing diarrhea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA021393869A CN1476873A (en) | 2002-08-20 | 2002-08-20 | Medicine composition for curing diarrhea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1476873A true CN1476873A (en) | 2004-02-25 |
Family
ID=34147424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA021393869A Pending CN1476873A (en) | 2002-08-20 | 2002-08-20 | Medicine composition for curing diarrhea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1476873A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106361779A (en) * | 2016-08-31 | 2017-02-01 | 祁守岗 | Nano-berberine and nano-spirulina mixing tablet |
| CN106474123A (en) * | 2016-08-31 | 2017-03-08 | 胡建华 | A kind of nanometer coptis plain piece |
-
2002
- 2002-08-20 CN CNA021393869A patent/CN1476873A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106361779A (en) * | 2016-08-31 | 2017-02-01 | 祁守岗 | Nano-berberine and nano-spirulina mixing tablet |
| CN106474123A (en) * | 2016-08-31 | 2017-03-08 | 胡建华 | A kind of nanometer coptis plain piece |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101249417B (en) | Concave-convex bar stone clay-trihydrate alumina/iron nano composite adsorbing agent, preparation and applications | |
| Breen | The characterisation and use of polycation-exchanged bentonites | |
| Yin et al. | Research and application progress of nano-modified coating in improving the durability of cement-based materials | |
| Wang et al. | Palygorskite nanomaterials: structure, properties, and functional applications | |
| CN104069801B (en) | The preparation method of attapulgite clay nano stick crystal complex microsphere adsorbent | |
| Abukhadra et al. | Synthesis and characterization of kaolinite nanotubes (KNTs) as a novel carrier for 5-fluorouracil of high encapsulation properties and controlled release | |
| Sarkar et al. | Reduced graphene oxide decorated superporous polyacrylamide based interpenetrating network hydrogel as dye adsorbent | |
| CN1843911A (en) | Method for preparing silane coupler modified attapulgite | |
| CN102701552A (en) | Covering material for immobilized in-situ remediation of nitrogen in bottom sediment and preparation method thereof | |
| CN1830823A (en) | Treatment agent for textile dyeing waste water | |
| CN101058426A (en) | Environment-friendly modified bentonite and preparation method thereof | |
| CN111470513A (en) | Double-modified bentonite and preparation method thereof | |
| CN103933936A (en) | Preparation method and application of antibiotic composite adsorbent | |
| Mohsen et al. | Bio-mechanical efficacy for slag/fly ash-based geopolymer mingled with mesoporous NiO | |
| CN1476873A (en) | Medicine composition for curing diarrhea | |
| CN103554328A (en) | Method for preparing pH sensitive hydrogel for adsorbing heavy metal ions and product thereof | |
| CN1775288A (en) | Medicine for treating diarrhoea | |
| Kenawy et al. | Montmorillonite intercalated norfloxacin and tobramycin for new drug-delivery systems | |
| CN1621370A (en) | Nano highly effective amendment for sludge dehydration | |
| Deng et al. | Nanomaterials from mixed-layer clay minerals: structure, properties, and functional applications | |
| CN1385470A (en) | Organic composite rectorite and preparation process thereof | |
| CN107311496A (en) | Application of the magnetized water in cement stabilized macadam | |
| CN1018817B (en) | Process for preparing cross-linking clay with increased acidic property | |
| CN109675517A (en) | A kind of high temperature modified high alumina cement de-fluoridation adsorbent, preparation method and applications | |
| CN2730876Y (en) | Hollow body with porous in outer layer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |